Sage Journals: Discover world-class research

Free access

Review article

First published 2000-4

Novel Approaches to the Treatment of Hepatitis C Virus Infection

Brian W Dymock, Philip S Jones, Francis X Wilson

Antiviral Chemistry and Chemotherapy

Free access

Review article

First published 2012-5

Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection

Paul Y. Kwo

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2014-12

Sofosbuvir: A novel treatment option for chronic hepatitis C infection

Harmeet Kaur Bhatia, Harmanjit Singh, Nipunjot Grewal [...]

Journal of Pharmacology and Pharmacotherapeutics

Free access

Review article

First published 2017-2

Novel emerging treatments for hepatitis C infection: a fast-moving pipeline

Ara A. Kardashian, Paul J. Pockros

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025-9

Characterizing the impact of a novel electronic consultation platform on access to Hepatitis C treatment in Manitoba

Lauren J. MacKenzie, Laurie Ireland, Javier Mignone [...]

Healthcare Management Forum

Open access

Research article

First published 2015

A Novel Approach to Identify Candidate Prognostic Factors for Hepatitis C Treatment Response Integrating Clinical and Viral Genetic Data

Alicia Amadoz, Fernando Gonzáez-Candelas

Evolutionary Bioinformatics

Retricted access

Research article

First published 2016-9

Successful Treatment of a Hepatitis C–Positive Patient Who Received Kidney Transplant From a Hepatitis C–Positive Donor

Ioannis Papayannis, P. Patel

Progress in Transplantation

Free access

Research article

First published 2010-8

von Willebrand Factor Antigen: A Novel On-Treatment Predictor of Response to Antiviral Therapy in Chronic Hepatitis C Genotypes 1 and 4

Sibylle Pramhas, Monika Homoncik, Peter Ferenci [...]

Antiviral Therapy

Free access

Research article

First published 2009-1

Safety,pharmacokinetics and antiviral effect of BILB 1941,a novel hepatitis C virus RNA polymerase inhibitor,after 5 days oral treatment

Andreas Erhardt, Katja Deterding, Yves Benhamou [...]

Antiviral Therapy

Retricted access

Research article

First published 2004-09

The Development of a Modified Human IFN-α2b Linked to the Fc Portion of Human IgG1 as a Novel Potential Therapeutic for the Treatment of Hepatitis C Virus Infection

Tim D. Jones, Marian Hanlon, Beverley J. Smith [...]

Journal of Interferon & Cytokine Research

Search results